SCOPUS 정보 검색 플랫폼

Nature Clinical Practice Rheumatology

Volumn 4, Issue 7, 2008, Pages 350-351

Is mizoribine a new therapeutic agent for Sjögren's syndrome?

(2) Moutsopoulos, Haralampos M a Fragoulis, George E a

a UNIVERSITY OF ATHENS MEDICAL SCHOOL (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CEVIMELINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; METHOTREXATE; MIZORIBINE; PILOCARPINE; PLACEBO; PREDNISONE; RITUXIMAB; VINCRISTINE;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; DRY EYE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SALIVATION; SJOEGREN SYNDROME; SYMPTOM; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 47149083155 PISSN: 17458382 EISSN: 17458390 Source Type: Journal
DOI: 10.1038/ncprheum0823 Document Type: Article

Times cited : (9)

References (10)

1
- 0842281434
- The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases
- Routsias JG et al. (2004) The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta 340: 1-25
- (2004) Clin Chim Acta , vol.340 , pp. 1-25
- Routsias, J.G.¹

2
- 33744818170
- The role of epithelial cells in the initiation-and perpetuation of autoimmune lesions: Lessons from Sjögren's syndrome (autoimmune epithelitis)
- Mitsias DI et al. (2006) The role of epithelial cells in the initiation-and perpetuation of autoimmune lesions: Lessons from Sjögren's syndrome (autoimmune epithelitis). Lupus 15: 255-281
- (2006) Lupus , vol.15 , pp. 255-281
- Mitsias, D.I.¹

3
- 33646464386
- The management of Sjögren's syndrome
- Mavragani CP et al. (2006) The management of Sjögren's syndrome. Nat Clin Prect Rheumatol 2: 252-261
- (2006) Nat Clin Prect Rheumatol , vol.2 , pp. 252-261
- Mavragani, C.P.¹

4
- 36949026702
- Mycophenolate sodium treatment in patients with primary Sjögren syndrome: A pilot trial
- Wilieke P et al. (2007) Mycophenolate sodium treatment in patients with primary Sjögren syndrome: A pilot trial. Arthritis Res Ther 9: R115
- (2007) Arthritis Res Ther , vol.9
- Wilieke, P.¹

5
- 36949034505
- The future of biologic agents in the treatment of Sjögrens syndrome
- Meijer JM et al. (2007) The future of biologic agents in the treatment of Sjögrens syndrome. Clin Rev Allergy Immunol 32 292-297
- (2007) Clin Rev Allergy Immunol , vol.32 , pp. 292-297
- Meijer, J.M.¹

6
- 34548273657
- Emerging bidogical therapies in primary Sjögren's syndrome
- Ramos-Casals M and Brito-Zerón P (2007) Emerging bidogical therapies in primary Sjögren's syndrome. Rheumatology (Oxford) 46: 1389-1396
- (2007) Rheumatology (Oxford) , vol.46 , pp. 1389-1396
- Ramos-Casals, M.¹ Brito-Zerón, P.²

7
- 0035040691
- VX-497: A novel, selective IMPIDH inhibitor and immunosuppressive agent
- Jain J et al. (2001) VX-497: A novel, selective IMPIDH inhibitor and immunosuppressive agent. J Pharm Sci 90: 625-637
- (2001) J Pharm Sci , vol.90 , pp. 625-637
- Jain, J.¹

8
- 0016176544
- Mizuno K et al. (1974) Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (tokyo) 27: 775-782
- Mizuno K et al. (1974) Studies on bredinin. I. Isolation, characterization and biological properties. J Antibiot (tokyo) 27: 775-782

9
- 33947199783
- Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers
- Stypinski D et al. (2007) Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers. Br J Clin Pharmacol 63: 459-468
- (2007) Br J Clin Pharmacol , vol.63 , pp. 459-468
- Stypinski, D.¹

10
- 1042309499
- Efficacy of mizoribine treatment in patients with Sjögren's syndrome: An open pilot trial
- Nakayamada S et al. (2003) Efficacy of mizoribine treatment in patients with Sjögren's syndrome: An open pilot trial. Mod Rheumatol 13: 339-345
- (2003) Mod Rheumatol , vol.13 , pp. 339-345
- Nakayamada, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.